Literature DB >> 11992797

Imaging of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography.

Naomi Alazraki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11992797     DOI： 10.1016/s1091-255x(01)00058-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  9 in total

1.  Positron emission tomography: imaging tumor response.

Authors:  J F Eary; K A Krohn
Journal:  Eur J Nucl Med       Date:  2000-12

2.  FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients.

Authors:  P Magnani; A Carretta; G Rizzo; F Fazio; A Vanzulli; G Lucignani; P Zannini; C Messa; C Landoni; M C Gilardi; A Del Maschio
Journal:  J Cardiovasc Surg (Torino)       Date:  1999-10       Impact factor: 1.888

3.  Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.

Authors:  C G Diederichs; L Staib; J Vogel; B Glasbrenner; G Glatting; H J Brambs; H G Beger; S N Reske
Journal:  Pancreas       Date:  2000-03       Impact factor: 3.327

Review 4.  18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

Authors:  D M Rose; D Delbeke; R D Beauchamp; W C Chapman; M P Sandler; K W Sharp; W O Richards; J K Wright; M E Frexes; C W Pinson; S D Leach
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

5.  Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.

Authors:  D Delbeke; D M Rose; W C Chapman; C W Pinson; J K Wright; R D Beauchamp; Y Shyr; S D Leach
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

6.  18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma.

Authors:  C Franke; R Klapdor; K Meyerhoff; M Schauman
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

7.  Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.

Authors:  O S Hoekstra; A van Lingen; G J Ossenkoppele; R Golding; G J Teule
Journal:  Eur J Nucl Med       Date:  1993-12

8.  Fluorine-18-fluorodeoxyglucose uptake in pneumonia.

Authors:  L O Kapucu; C C Meltzer; D W Townsend; R J Keenan; J D Luketich
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

9.  FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study.

Authors:  N R Maisey; A Webb; G D Flux; A Padhani; D C Cunningham; R J Ott; A Norman
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640
  9 in total
  2 in total

1.  Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody.

Authors:  Julia Baguña Torres; James C Knight; Michael J Mosley; Veerle Kersemans; Sofia Koustoulidou; Danny Allen; Paul Kinchesh; Sean Smart; Bart Cornelissen
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

2.  Immuno-imaging of ICAM-1 in tumours by SPECT.

Authors:  Michael Mosley; Julia Baguña Torres; Danny Allen; Bart Cornelissen
Journal:  Nucl Med Biol       Date:  2020-02-25       Impact factor: 2.408
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.